DOI 10.1186/s12890-025-04004-1
Clinical efficacy of sitafloxacin-containing regimens for Mycobacterium avium complex pulmonary disease.
Аннотация
BACKGROUND
Fluoroquinolones (FQ) have shown efficacy against Mycobacterium avium complex (MAC) across experimental settings, in vitro and in vivo. Sitafloxacin (STFX) has demonstrated particularly strong anti-MAC activity, but clinical data on its effectiveness in treating MAC pulmonary disease (MAC-PD) are sparse. This study aimed to evaluate the efficacy of STFX-containing regimens in patients with MAC-PD.
METHODS
This retrospective cohort study included 50 patients with MAC-PD who received STFX-containing regimens for ≥6 months at a single center between January 2015 and March 2024. Patients were categorized into four groups: Group 1, STFX-treated without surgery (n = 49); Group 2, STFX started ≥6 months after guideline-based treatment (GBT) began (n = 40); Group 3, poor radiologic response to GBT (n = 38); and Group 4, persistent positive sputum cultures at STFX initiation (n = 19). Primary outcomes assessed at six months included radiologic improvement using the NICE (Nodule, Infiltration, Cavity, Ectasis) score, sputum culture conversion (defined as ≥2 consecutive negative cultures obtained ≥4 weeks apart), and symptom improvement (using the COPD Assessment Test [CAT] score).
RESULTS
Radiologic improvement, symptomatic improvement, and sputum culture conversion were observed in 18.4%, 19.1%, and 20.0% of patients in Group 1; 12.5%, 20.0%, and 12.5% in Group 2; 13.2%, 18.4%, and 13.3% in Group 3; and 5.3%, 15.8%, and 12.5% (2 of 16 evaluable patients) in Group 4, respectively. The two patients who achieved culture conversion had clarithromycin-susceptible strains, non-cavitary disease, and received concomitant ethambutol.
CONCLUSIONS
STFX-containing regimens demonstrated modest and overall limited efficacy in patients with MAC-PD, with fewer than 20% achieving radiologic, symptomatic, or microbiological improvement across all groups. STFX may be considered an alternative adjunct when standard therapies are not feasible; however, its overall therapeutic role appears limited.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.